ramelteon has been researched along with Disease Models, Animal in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Bunte, S; Goetze, L; Heinen, A; Hollmann, MW; Huhn, R; Mathes, A; Raupach, A; Stroethoff, M; Torregroza, C | 1 |
| Gu, C; Liu, CF; Liu, JY; Sun, HY; Wang, F; Wang, GH; Wei, SZ; Zhang, YT | 1 |
| Chen, X; Guan, F; Jiang, C; Lan, X; Lu, H; Wang, J; Wang, Z; Yang, X; Zang, W; Zhang, K; Zhu, C | 1 |
| Fink, T; Glas, M; Kiefer, D; Kleber, A; Mathes, AM; Rensing, H; Reus, E; Volk, T; Wolf, A; Wolf, B; Wolff, M | 1 |
| Cai, C; Gao, C; Guan, JH; Guo, J; Huang, YL; Liang, XB; Qian, LQ; Zhao, GP | 1 |
| Abend, M; Fink, T; Glas, M; Kleber, A; Mathes, AM; Ruf, CG; Volk, T; Wolf, A; Wolf, B | 1 |
| Heymann, P; Kubulus, D; Mathes, AM; Rensing, H; Waibel, L; Weiler, J; Wolf, B | 1 |
| Jiang, P; O'Hara, BF; Striz, M; Wisor, JP | 1 |
| Christie, MA; Connolly, NP; Jeffrey, BA; Lee, E; McCoy, JG; McKenna, JT; Strecker, RE; Ward, CP | 1 |
| Baño Otalora, B; Bonet-Costa, V; Camello, PJ; Gambini, J; Madrid, JA; Popovic, M; Popovic, N; Reiter, RJ; Rol, MÁ; Viña, J | 1 |
| Cruź, CM; France, CP; Koek, W; McMahon, LR; Weltman, RH | 1 |
12 other study(ies) available for ramelteon and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
The Melatonin Receptor Agonist Ramelteon Induces Cardioprotection that Requires MT2 Receptor Activation and Release of Reactive Oxygen Species.
Topics: Animals; Cardiovascular Agents; Disease Models, Animal; Indenes; Isolated Heart Preparation; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats, Wistar; Reactive Oxygen Species; Receptor, Melatonin, MT2; Signal Transduction; Ventricular Function, Left | 2020 |
Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming.
Topics: Animals; Disease Models, Animal; Indenes; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Neurodegenerative Diseases; Parkinson Disease; Receptor, Melatonin, MT1 | 2021 |
Melatonin receptor activation provides cerebral protection after traumatic brain injury by mitigating oxidative stress and inflammation via the Nrf2 signaling pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Astrocytes; Brain Edema; Brain Injuries, Traumatic; Cerebral Cortex; Disease Models, Animal; Gene Expression Regulation; Glutathione Peroxidase; Indenes; Inflammation; Interleukin-10; Interleukin-1beta; Interleukin-4; Kelch-Like ECH-Associated Protein 1; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; NF-E2-Related Factor 2; Oxidative Stress; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Signal Transduction; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2019 |
Melatonin receptors mediate improvements of survival in a model of polymicrobial sepsis.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Indenes; Interleukin-10; Interleukin-6; Male; Melatonin; Mice; Mice, Inbred C3H; Mice, Knockout; Rats; Rats, Sprague-Dawley; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Receptors, Melatonin; Sepsis; Tryptamines; Tumor Necrosis Factor-alpha | 2014 |
Effects of Kaixin Powder on melatonin receptor expression and (125)I-Mel binding affinity in a rat model of depression.
Topics: Animals; Brain; Depression; Disease Models, Animal; Drinking Behavior; Drugs, Chinese Herbal; Gene Expression Regulation; Indenes; Iodine Radioisotopes; Male; Melatonin; Rats, Wistar; Receptors, Melatonin; Weight Gain | 2015 |
Melatonin or ramelteon therapy differentially affects hepatic gene expression profiles after haemorrhagic shock in rat--A microarray analysis.
Topics: Animals; Antioxidants; Biomarkers, Tumor; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Indenes; Liver; Male; Melatonin; Oligonucleotide Array Sequence Analysis; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Shock, Hemorrhagic; Tumor Cells, Cultured | 2015 |
Selective activation of melatonin receptors with ramelteon improves liver function and hepatic perfusion after hemorrhagic shock in rat.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Indenes; Infusions, Intravenous; Liver Circulation; Liver Diseases; Liver Function Tests; Male; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Melatonin; Sensitivity and Specificity; Shock, Hemorrhagic; Tryptamines | 2008 |
Effects of ramelteon and triazolam in a mouse genetic model of early morning awakenings.
Topics: Animals; Circadian Rhythm; Darkness; Disease Models, Animal; Indenes; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Phenotype; Photoperiod; Random Allocation; Receptors, Melatonin; Sleep Initiation and Maintenance Disorders; Time Factors; Tranquilizing Agents; Triazolam; Wakefulness | 2009 |
Chronic ramelteon treatment in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antipsychotic Agents; Apoptosis; Brain; Cognition Disorders; Disease Models, Animal; Follow-Up Studies; Humans; Indenes; Maze Learning; Mice; Mice, Transgenic; Mutation; Plaque, Amyloid; Poly(ADP-ribose) Polymerases; Presenilin-1; Time Factors | 2012 |
Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Body Temperature; Circadian Rhythm; Disease Models, Animal; Hippocampus; Indenes; Male; Melatonin; Memory; Mice; Mice, Transgenic; Motor Activity; Mutant Proteins; Oxidative Stress; Presenilin-1; Receptors, Melatonin | 2012 |
Acute and chronic effects of ramelteon in rhesus monkeys (Macaca mulatta): dependence liability studies.
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzodiazepines; Conditioning, Classical; Conditioning, Operant; Discrimination Learning; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Flumazenil; GABA Modulators; Hypnotics and Sedatives; Indenes; Macaca mulatta; Male; Methylcellulose; Midazolam; Neuropsychological Tests; Receptors, Melatonin; Substance-Related Disorders; Time Factors | 2006 |